Patents
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
07/2002
07/18/2002US20020094983 Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
07/18/2002US20020094453 Metal coordination compound, luminescence device and display apparatus
07/18/2002DE10102053A1 Piperazinylcarbonyl-quinoline and piperazinylcarbonyl-isoquinoline derivatives useful for treatment of e.g. schizophrenia, psychoses, depression, Parkinson's disease and Alzheimer's disease
07/18/2002CA2434205A1 1,1-disubstituted cyclic inhibitors of matrix metalloprotease and tnf-.alpha.
07/18/2002CA2434152A1 Therapeutic heterocyclic compounds
07/18/2002CA2434015A1 Therapeutic chroman compounds
07/18/2002CA2433950A1 Therapeutic chromone compounds
07/17/2002EP1222920A2 Mitochondria protecting agents for treating mitochondria associated diseases
07/17/2002EP0939629A4 Thiol sulfonamide metalloprotease inhibitors
07/17/2002CN1359373A 6[(aryl and heteroaryl)oxy] methyl] naphthalene-2-carboximidamide derivatives, preparation and therapeutic application thereof
07/17/2002CN1087725C Enhancement of the effect of drugs by deuteration
07/16/2002US6420427 Prevention and/or treatment of rheumatoid diseases, arthrosteitis, unusual bone resorption, osteoporosis, periodontitis, interstitial nephritis, arteriosclerosis, pulmonary emphysema, cirrhosis, cornea injury
07/16/2002US6420424 CCR-3 receptor antagonists
07/16/2002US6420423 Pesticides
07/16/2002US6420387 Antitumor
07/16/2002US6420363 Mono- or polyenic carboxylic acid derivatives
07/11/2002WO2002053543A1 Pyridone derivative having affinity for cannabinoid 2-type receptor
07/11/2002WO2002036734A3 Aza-and polyaza-naphthalenyl ketones useful as hiv integrase inhibitors
07/11/2002WO2001024785A3 Dihydroorotate dehydrogenase inhibitors for the treatment of viral-mediated diseases
07/11/2002US20020091120 2-substituted heterocyclic compounds for treating multidrug resistance
07/11/2002US20020091089 (Substituted)acyl dipeptidyl inhibitors of the ICE/ced-3 family of cysteine proteases
07/10/2002EP1221441A2 LTA4 Hydrolase inhibitors
07/10/2002EP1221440A1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators
07/10/2002EP1221434A1 Hydrocarbon compound, material for organic electroluminescent element and organic electroluminescent element
07/10/2002CN1358169A N-alkoxyalkyl-N,N-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same
07/10/2002CN1357541A Phosphatidase A2 inhibitor and its prepn process and use
07/10/2002CN1087294C Novel compounds
07/10/2002CN1087285C Basic group substituted benzoyl guaniazine, its preparing process, its use as medicine or diagnostic reagent, and medicine containing the same
07/10/2002CN1087283C New LH-RH antigonists with improved effectiveness
07/09/2002US6417387 α-and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
07/09/2002US6417367 Methods of making quinoline amides
07/09/2002US6417366 Chemical intermediate for macrolactone antibiotic
07/09/2002CA2217455C New substituted derivatives, of biphenyl or phenylpiridine, their preparation process and the pharmaceutical compositions that contain them
07/04/2002WO2002051830A1 Carboxamides for use as telomerase inhibitors
07/04/2002WO2002036556A3 Acylaminoalkyl-substituted benzenesulfonamide derivatives
07/04/2002WO2001098275A3 1-aryl-4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents
07/04/2002US20020086996 N-cyanomethyl amides which are cysteine protease inhibitors; treating osteoporosis; mixtures with bisphosphonates
07/04/2002US20020086887 N-Acylsulfonamide apoptosis promoters
07/04/2002DE10065043A1 Carbonsäureamide, diese Verbindungen enthaltene Arzneimittel, deren Verwendung und Herstellung Carboxamides, medicines, these compounds contained, their use and production
07/03/2002EP1219607A1 Integrase inhibitors containing aromatic heterocycle derivatives
07/03/2002EP1218345A1 Method of making metal 8-quinolinolato complexes
07/03/2002EP1218336A2 Melanin concentrating hormone antagonist
07/03/2002EP0860433B1 Quinoline derivatives and quinazoline derivatives inhibiting autophosphorylation of growth factor receptor originating in platelet and pharmaceutical compositions containing the same
07/03/2002CN1356991A Quinoline and quinoxaline compounds as PDGF-R and/or LCD tyrosine kinase inhibitors
07/03/2002CN1356990A Bicyclic heterocycles, medicaments contg. these compounds, their use and methods for prodn. thereof
07/03/2002CN1356983A Tri-aryl acid derivatives as PPAR receptor ligands
07/03/2002CN1356977A Glucagon antagonists/inverse agonists
07/03/2002CN1356038A Fungiciding mixture
07/02/2002US6414012 Heterocyclic derivatives, method of production thereof and pharmaceutical use thereof
07/02/2002US6413985 Selective antagonists for the strychnine insensitive glycine binding site associated with the nmda receptor complex.
07/02/2002US6413969 Gatifloxacin pentahydrate
07/02/2002US6413956 Substituted 4-oxo-quinoline-3-carboxamides
07/02/2002CA2104839C Arylazo chromoionophores
07/02/2002CA2065846C Quinolone carboxylic acid derivatives
06/2002
06/27/2002WO2002050081A2 Antimicrobial agents
06/27/2002WO2002050041A1 Dihydroindole and tetrahydroquinoline derivatives
06/27/2002WO2002050040A1 Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperazine-containing moiety and their use as antibacterial agents
06/27/2002WO2002049993A2 High affinity small molecule c5a receptor modulators
06/27/2002WO2002049632A1 Inhibitors against the production and release of inflammatory cytokines
06/27/2002WO2002024652B1 Compounds and methods for diagnosing and treating amyloid-related conditions
06/27/2002WO2001018171A3 Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
06/27/2002US20020082424 Alkylating an aryl halide with 1,3-dichloropropene and n-tetrabutylammonium iodide catalyst for forming vinyl chloride compound which is subjected to cyclization using tribuytyl tin hydride, catalyst and toluene as the solvent
06/27/2002US20020082283 Increasing the function of the N-methylaspartic acid (NMDA) receptor without the inherent side-effects associated with modulation of the glutamate binding site
06/27/2002US20020082276 Quinoline derivatives as anti-inflammatory agents
06/27/2002US20020082274 Preparation of sodium-hydrogen exchanger type-1 inhibitors
06/27/2002US20020082262 Regulate the cellular transport proteins P- glycoprotein and MRP1 , which are the proteins believed to be responsible for multidrug resistance in cancer patients
06/27/2002US20020082257 Elevates ATP binding cassette transporter 1 expression thereby increasing efflux of cholesterol from cells by active transfer into high density lipoproteins
06/26/2002EP1216980A1 Carboxylic acid derivatives and drugs containing the same
06/26/2002CN1355697A IL-8 receptor antagonists
06/26/2002CN1086702C 4-hydroxy-piperidine-derivatives
06/26/2002CN1086569C Dehydration plant
06/25/2002US6410783 Salt formation with dicamba; dehydration
06/25/2002US6410563 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
06/25/2002US6410561 Analgesics
06/25/2002US6410558 Using indole or quinoline compound
06/25/2002US6410529 Phenyl urea and phenyl thiourea derivatives as HFGAN72 antagonists
06/25/2002US6410521 Nutritional supplements for stimulating bone growth
06/25/2002US6410480 Plant safening agents and growth regulators for controlling weeds and grasses; post/preemergence herbicides
06/25/2002US6409812 AZO compounds and process for producing the same
06/20/2002WO2002048113A1 Cyclization process step in the making of quinolones and naphthyridines
06/20/2002WO2002048112A2 7-heterocyclyl quinoline and thieno[2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormone
06/20/2002WO2002047687A1 Urotensin-ii receptor antagonists
06/20/2002WO2002047456A2 Urotensin-ii receptor antagonists
06/20/2002WO2002012214A3 Non-imidazole aryloxyalkylamines as h3 receptor ligands
06/20/2002WO2002004422A3 Heterocycle carboxamides as antiviral agents
06/20/2002US20020077481 For use in the synthesis of peptides and/or for the manufacture of pharmaceutically active substances or corresponding intermediates
06/20/2002US20020077455 Protease inhibitors
06/20/2002US20020077338 HIV protease inhibitors
06/20/2002US20020077335 For therapy of asthma, chronic obstructive pulmonary disease, airway hyperreactivity, skin disorders and itch (for example, atopic dermatitis and cutaneous wheal and flare), neurogenic inflammation and Parkinson's disease, psychosis
06/19/2002EP1214292A1 Tyrosine derivatives
06/19/2002CN1354746A 6.7-disubstituted-5,8-quinolinedione derivatives as antifungal agent
06/18/2002US6407248 α-unsaturated amines, their production and use
06/18/2002US6407096 Benzene fused heterocyclic derivatives having thromboxane A2 receptor antagonistic activity and prostaglandin I2 Agonistic activity and application thereof
06/13/2002WO2002046181A2 Abca-1 elevating compounds against coronary artery disease or atherosclerosis
06/13/2002WO2002046173A1 Fused heteroaromatic glucokinase activators
06/13/2002WO2002046172A2 Substituted 1, 3, 5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis
06/13/2002WO2002046163A2 Quinoline derivatives and their use as anti-epileptics
06/13/2002WO2002046141A2 Coumpounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis
06/13/2002WO2002046129A2 Inhibitors of histone deacetylase
06/13/2002WO2002045703A2 Mixtures or organic compounds for the treatmentof airway diseases